Influenza Neuraminidase Inhibitor Susceptibility Assay Kit

-20°C

Highly Sensitive; Includes Viral Neuraminidase control

gel pack

12 months

Viral Neuraminidase

• Rapid assessment of neuraminidase activity in influenza virus isolates • Characterization of neuraminidase inhibitor susceptibility of known or newly emergent influenza strains • High-throughput screening of novel neuraminidase inhibitor antiviral drugs

• Influenza virus (type A or B, from any host species) isolates (propagated from embryonated chicken eggs or cultured MDCK cells) • Purified or recombinant neuraminidase enzyme preparations

influenza

Biovision supplies other types of Assays as 1.

Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.